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Alcoholism is a pervasive disorder perpetuated in part to relieve negative mood states like anxiety experienced during alcohol withdrawal.
Emerging evidence demonstrates a role for the serotonin-rich dorsal raphe (DR) in anxiety following ethanol withdrawal. The current
study examined the effects of chronic ethanol vapor exposure on the DR using slice electrophysiology in male DBA2/J mice. We found
that chronic ethanol exposure resulted in deficits in social approach indicative of increased anxiety-like behavior at both 24 h and
7 days post-ethanol exposure. At 24 h post-ethanol exposure, we observed increased excitability and decreased spontaneous inhibitory
transmission (inhibitory postsynaptic currents, IPSCs) in the DR. At 7 days post-ethanol exposure, we observed increased spontaneous
and miniature excitatory transmission (excitatory postsynaptic currents, EPSCs). Because acute ethanol alters GABA transmission in other
brain regions, we assessed the effects of ex vivo ethanol (50 mM) on miniature IPSCs (mIPSCs) in the DR 24-h post-ethanol exposure. Bath
application of ethanol enhanced the amplitude of mIPSCs in cells from ethanol-naive and chronic intermittent ethanol-exposed (CIE) mice,
but significantly enhanced the frequency of mIPSCs only in cells from CIE mice, suggesting that DR neurons are more sensitive to the
inhibitory effects of acute ethanol following CIE. On the basis of these findings, we hypothesize that net excitation of DR neurons following
chronic ethanol exposure contributes to enhanced anxiety during ethanol withdrawal, and that increased sensitivity of DR neurons to
subsequent ethanol exposure may mediate acute ethanol’s ability to relieve anxiety during ethanol withdrawal.














































Alcoholism is a pervasive chronic, relapsing disorder that is
characterized by increased prevalence of negative mood
states such as anxiety during abstinence (Hamilton et al,
2013). Alcohol’s ability to relieve such negative mood states
is positively associated with craving for alcohol (Fox et al,
2012) and is a common motivation to resume alcohol
consumption (Glöckner-Rist et al, 2013).
Serotonin is a monoamine neurotransmitter that is widely
expressed throughout the central nervous system, where it
has a principle role in stress responses, mood regulation,
and, a growing body of evidence suggests, alcohol use
disorders. Dysfunction in the serotonin system contributes
significantly to the symptoms of many mood disorders
(Miller et al, 2013; Arango et al, 2001; López-Figueroa et al,
2004) that commonly present with alcohol use disorders
(Hasin et al, 2007), and alterations in serotonin markers are
well-documented in human alcoholics (Underwood et al,
2007; Pivac et al, 2004; Beck et al, 1983). In preclinical
models, ethanol drinking and enhanced anxiety-like beha-
vior stemming from chronic ethanol exposure are attenu-
ated by serotonergic compounds (Yoshimoto et al, 2012;
Overstreet et al, 2006), whereas feelings of nervousness,
anxiety, and craving in alcoholics are exacerbated by the
serotonin agonist meta-chlorophenylpiperazine (Umhau
et al, 2011; Krystal et al, 1996). Moreover, a series of
studies from the Kranzler group demonstrate that in a
subpopulation of alcohol-dependent individuals, treatment
with selective serotonin reuptake inhibitors (SSRIs) can
increase both alcohol consumption and anxiety, and worsen
treatment outcomes relative to placebo (Kranzler et al, 2013;
Kranzler et al, 2012; Kranzler et al, 1996; Dundon et al,
2004). Taken together, these data suggest that dysregulation
in the serotonin system underlies negative mood states
associated with alcohol use disorders.
The majority of serotonin in the brain arises from the
dorsal raphe nucleus (DR), a midbrain region that is known
to modulate neurophysiological and behavioral responses to
stress. Neurons containing serotonin are found throughout
this structure and are especially enriched in the dorso-
medial and ventromedial aspects of the DR (Fu et al, 2010).
This portion of the DR is innervated by limbic inputs of
particular interest to the study of alcoholism and negative
affect, such as the central nucleus of the amygdala and bed
nucleus of the stria terminalis (Hale et al, 2012). Emerging
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preclinical evidence suggests that the DR is involved in
behavioral phenotypes associated with ethanol (Tomkins
et al, 1994; Hwa et al, 2013; Takahashi et al, 2010)
including enhanced anxiety following chronic ethanol
exposure (Knapp et al, 2011; Huang et al, 2010; Overstreet
et al, 2006). However, to date, little is known about the
effects of chronic ethanol exposure on the functional
activity of the DR.
In the current study, we examined the effects of chronic
ethanol exposure on DR activity in DBA2/J mice. As a high
anxiety and stress-vulnerable strain (Millstein and Holmes
2007), DBA2/J mice resemble human alcoholics, for whom
stress and anxiety disorders typically precede the develop-
ment of alcoholism (Marquenie et al, 2007). In addition,
DBA2/J mice have high-functioning serotonin transporters
(Carneiro et al, 2009), a trait that predicts depression,
anxiety, and neuroticism among individuals that have a
positive family history of alcoholism (Lovallo et al, 2014).
Here, we demonstrate that DBA2/J mice display robustly
enhanced anxiety during ethanol withdrawal much like
human alcoholics. Following a regimen of chronic ethanol
vapor exposure and withdrawal to establish an ethanol




Male DBA2/J mice (Jackson Laboratories, Bar Harbor, ME)
arrived at 6 weeks of age and were immediately housed with
littermates (2–4 per cage) in a vivarium maintained on a
12-h/12-h light/dark cycle with lights off at 0700 hours. Mice
had access to standard rodent chow and water ad libitum
for the duration of experiments.
Chronic Intermittent Ethanol Exposure
Five to eleven days after arrival, mice began a 5-day regimen
of exposure to chronic intermittent ethanol vapors (chronic
intermittent ethanol-exposed; CIE). This protocol has been
used previously to induce behavioral indices of dependence
in rodents (Becker and Lopez, 2004). Briefly, daily begin-
ning at 1630 h, mice were removed from their home cages,
injected with the alcohol dehydrogenase inhibitor pyrazole
(1 mmol/kg) and placed with cagemates in vapor chambers,
where they were continuously exposed to ethanol vapor and
oxygen (15 l/min) for 16 consecutive hours. The relative
flow rate of ethanol vapor and oxygen was carefully
maintained to yield target blood ethanol concentrations
(BECs) of 150–200 mg/dl. At 0900 hours, mice were
removed from the vapor chambers and returned to their
home cages. This cycle of ethanol vapor exposure and
withdrawal was repeated over the next 4 days, resulting in
5 16-h exposures to ethanol vapors and 5 8-h periods of
ethanol withdrawal. Following the final ethanol vapor
exposure, mice remained in their home cages without
disturbance for the duration of withdrawal (24 h or 7 days).
A control group underwent identical procedures, including
injections of pyrazole (1 mmol/kg) but was exposed to
forced air (air-exposed; AE) rather than ethanol vapors.
BECs were assessed in two additional cohorts of mice: one
cohort of AE and ethanol-exposed mice was used to assess
BECs immediately following removal from ethanol vapor
exposure and a second cohort of AE and ethanol-exposed
mice was used to assess BECs 24 h following removal from
ethanol vapor exposure. Briefly, mice were restrained, and
B20 ml of blood was collected from a small incision made
in the tail. Plasma extracted from each blood sample was
analyzed using the Analox Alcohol Analyzer (Analox
Instruments).
Social Approach
Mice from CIE and AE groups were injected with buspirone
(1 mg/kg, i.p.) or 0.9% saline 30 min before behavioral
testing in the social approach apparatus, a three-chambered
Plexiglass container divided by two panels with a small
opening at the base to allow movement between the
chambers as described previously (Moy et al, 2009). Follow-
ing a 10-min habituation to the test chamber, during which
crossings between chambers were observed, the time spent
sniffing a novel mouse vs an empty cage was evaluated over
10 min. Two cohorts of mice were used to evaluate
CIE effects on social approach, following either 24 h of
withdrawal or 7 days of withdrawal.
Electrophysiology
Twenty-four hours or 7 days following the final ethanol
vapor exposure, mice were killed via deep isoflurane
anesthesia, and brain slices containing the DR were
prepared as previously described (Li et al, 2012). Slice
electrophysiology was conducted to assess the effects of CIE
on basal functioning of neurons in the medial aspect of the
DR using previously published methods (Li et al, 2012). In
light of emerging data suggesting that the dorsomedial and
ventromedial portions of the DR are especially relevant to
anxiety-like phenotypes (Hale et al, 2012), cellular record-
ings were focused in these subregions. The effects of CIE on
excitability parameters were first assessed in current clamp
using a potassium gluconate-based intracellular solution
(in mM: 135 Kþ gluconate, 5 NaCl, 2 MgCl2, 10 HEPES, 0.6
EGTA, 4 Na2ATP, 0.4 Na2GTP, pH 7.3, 285–290 mOsmol).
The resting membrane potential of the cell was noted before
an increasing amount of current was injected (beginning at
0 pA) to assess the amount of current required to fire an
action potential (termed the rheobase) and the membrane
potential at which an action potential first fired. The
number of action potentials fired at a given amount of
current (0–200 pA; increased 10 pA per step) was also
assessed. The effects of CIE on basal synaptic transmission
was assessed in voltage clamp by adjusting the membrane
potential and using a cesium methanesulfonate-based
intracellular solution (in mM: 135 cesium methanesulfo-
nate, 10 KCl, 1 MgCl2, 0.2 EGTA, 2 QX-314, 4 MgATP,
0.3 GTP, 20 phosphocreatine, pH 7.3, 285–290 mOsmol).
Excitatory transmission was recorded at  55 mV, the
reversal potential for GABAA-mediated events and inhi-
bitory transmission was recorded at þ 10 mV, the
reversal potential for AMPAR-mediated events. These
experiments were repeated in the presence of the sodium
channel blocker tetrodotoxin (0.5 mM) to assess the effects
of CIE on network-independent synaptic transmission.
Chronic ethanol and dorsal raphe function
EG Lowery-Gionta et al
591
Neuropsychopharmacology
To examine acute ethanol effects on inhibitory transmis-
sion, and to determine whether it is altered by CIE,
inhibitory events were recorded in voltage clamp at
 70 mV using a cesium chloride-based intracellular solu-
tion (in mM: 130 CsCl, 10 EGTA, 10 HEPES, 2 MgATP, 0.2
NaGTP, pH 7.3, 285–290 mOsmol) in the presence of
tetrodotoxin (0.5 mM) and the glutamate receptor antagonist
kynurenic acid (3 mM). After a stable baseline was recorded,
acute ethanol (50 mM) was bath applied at a rate of 2 ml/
min for 10 min. The GABAA receptor antagonist picrotoxin
(200 mM) was then applied in addition to ethanol to confirm
that these events were GABA mediated (Fleming et al, 2007).
Parallel experiments were conducted in age-matched DBA
mice maintained under identical colony housing conditions
but not subjected to AE or CIE protocols (naive) to control
for potential effects of stress on electrophysiological
parameters. Naive mice did not differ from AE mice in
any of the assessed parameters (see Supplementary
Materials).
Statistics
BECs were analyzed using a repeated measures analysis of
variance (ANOVA) to assess between-group (CIE vs AE)
differences immediately following removal from ethanol
exposure and an unpaired t-test to assess between-group
(CIE vs AE) differences at 24 h post ethanol exposure.
Behavioral data were analyzed using two-way ANOVAs to
assess between-group (CIE vs AE) and between-treatment
(buspirone vs vehicle) differences. All significant ANOVA
terms were further analyzed for specific differences using
Bonferroni post hoc tests. For all between-group compar-
isons that violated homogeneity of variance assumptions
(deduced using F tests to compare variance), Welch’s t-tests
were performed and, where appropriate, then corrected for
multiple comparisons with a Bonferonni correction. A priori
hypotheses about between-group differences in behavior
were assessed using unpaired t-tests. Electrophysiologcal
data were analyzed using unpaired t-tests or Welch’s t-tests,
where appropriate, to assess the differences between groups
(CIE vs AE, AE vs naive). Grubb’s test was used to identify
statistical outliers and only one outlier was removed per
group. Repeated measures two-way ANOVAs with Bonfer-
onni-adjusted multiple comparisons as post hocs were used
to assess between-group differences in the responses to
ascending steps of current injection and bath application of
acute ethanol. All values presented are means±SEM and
significance was accepted when po0.05.
RESULTS
Buspirone Attenuates Chronic Ethanol-Induced Deficits
in Social Approach
The DR is implicated in behavioral stress and negative
affective responses, and emerging evidence demonstrates its
role in anxiety following chronic ethanol exposure
(Overstreet et al, 2006). To confirm that our model of
ethanol exposure elicits anxiety that involves the serotonin
system, we assessed chronic ethanol effects on social
approach. First, we characterized BECs immediately follow-
ing CIE and 24 h post CIE to validate this method of ethanol
exposure in DBA2/J mice (see Figure 1). To verify that CIE
mice achieved pharmacologically relevant levels of intox-
ication (ie, 4100 mg/dl), BECs were assessed immediately
upon removal from ethanol exposure on days 1 and 3. The
results of a two-way ANOVA showed a significant main
effect of ethanol treatment (F(1, 12)¼ 76.79, po0.0001).
The main effect of time (F(1, 12)¼ 0.3541, p40.05) and the
interaction between time and ethanol treatment (F(1,
12)¼ 0.4195, p40.05) were not significant. Bonferonni post
hoc analyses revealed that BECs in CIE mice were
significantly higher than AE mice immediately following
ethanol exposure. To verify that ethanol was no longer
present at 24 h of withdrawal, BECs were assessed in an
additional cohort of mice 24 h following removal from
ethanol exposure. The results of an unpaired t-test showed
that CIE mice did not significantly differ from AE mice in
BECs (t(8)¼ 1.243, p40.05), demonstrating that ethanol
has been fully metabolized at this time point. We then
examined chronic ethanol effects on social approach during
early (24 h post ethanol exposure) and late (7 days post
ethanol exposure) withdrawal and the potential role of
serotonin in this behavior using systemic administration of
the 5HT1A-R agonist buspirone in two separate cohorts. In
this model, reductions in social approach with a novel
mouse are interpreted as an indication of increased anxiety
(Knapp et al, 2004; Moy et al, 2007). To assess CIE or drug
effects on overall exploration, we assessed the number of
crossings between chambers during the 10-min habituation
period (see Figure 2a and b). The results of a two-way
ANOVA revealed a significant main effect of ethanol
treatment at both 24 h and 7 days post ethanol exposure
(F(1, 33)¼ 13.47, p¼ 0.0008 for 24 h and F(1, 33)¼ 6.147,
p¼ 0.0184 for 7 days). The main effect of drug treatment as
well as the ethanol drug treatment interaction were not
significant at either time point (F(1, 33)¼ 0.06653, p40.05
for drug treatment at 24 h; F(1, 33)¼ 0.05978, p40.05 for
drug ethanol treatment interaction at 24 h; F(1, 33)¼
0.6537, p40.05 for drug treatment at 7 days; F(1, 33)¼
0.009, p40.05 for drug ethanol treatment interaction at
7 days). These results show that chronic ethanol exposure
Figure 1 Chronic ethanol exposure (CIE) induces pharmacologically
relevant blood ethanol concentrations (BECs) on days 1 and 3 of exposure.
At 24 h post-CIE (Post), BECs of CIE mice do not significantly differ from
those of air-exposed mice. * denotes significant between-group differences
(po0.05), ns denotes the absence of significant between-group differences;
n¼ 5–9 mice per group; error bars indicate SEM.
Chronic ethanol and dorsal raphe function
EG Lowery-Gionta et al
592
Neuropsychopharmacology
induces lasting deficits in exploratory behavior. For social
approach, the results of a two-way ANOVA revealed
significant main effects of ethanol treatment (F(1,
34)¼ 7.131, p¼ 0.0115), drug treatment (F(1, 34)¼ 5.182,
p¼ 0.0292), and a significant ethanol drug treatment
interaction (F(1, 34)¼ 5.905, p¼ 0.0205) at 24 h post ethanol
exposure (see Figure 2c). Bonferroni post hoc analyses
revealed that at 24 h post ethanol exposure, vehicle-treated
CIE mice spent significantly less time interacting with the
novel mouse than vehicle-treated AE mice (po0.05).
Pretreatment with buspirone significantly attenuated defi-
cits in social approach in CIE mice (po0.05), but did not
alter social approach in AE mice (p40.05). At 7 days post-
ethanol exposure, the results of a two-way ANOVA revealed
significant main effects of ethanol treatment (F(1, 35)¼
4.692, p¼ 0.0372) and drug treatment (F(1, 35)¼ 9.763,
p¼ 0.0036), but the interaction was not significant (F(1,
35)¼ 0.8817, p40.05; see Figure 2d). Differences between
vehicle-treated AE and CIE mice were assessed on the basis
of the a priori hypothesis that CIE would reduce social
approach at 7 days, an effect that was confirmed by an
unpaired t-test (t(18)¼ 4.149, p¼ 0.0006). Likewise, an
unpaired t-test confirmed our a priori hypothesis that
buspirone would attenuate CIE-induced reductions in social
approach at 7 days post-ethanol exposure (t(17)¼ 3.232,
p¼ 0.0049) without effects in AE mice (Welch’s
t(10.40)¼ 1.420, p40.05). Together, these results indicate
that CIE induces both short-term and lasting deficits in both
exploratory behaviors and social approach. However, it
appears that only deficits in social approach involve the
serotonin system, demonstrating a role for serotonin in
anxiety following chronic ethanol exposure.
Chronic Ethanol Exposure Enhances the Activity and
Excitability of DR Neurons
On the basis of our results with buspirone, we hypothesized
that enhanced anxiety may result from increased DR activity
induced by chronic ethanol exposure. We therefore used
whole-cell-slice electrophysiology to assess chronic ethanol-
induced alterations in excitability at 24 h and 7 days post-
ethanol exposure. Unpaired t-tests revealed no between-
group differences in resting membrane potential, the
membrane potential at which the first action potential was
fired, or the rheobase at 24 h post-ethanol exposure. Similar
null results were observed at 7 days post-ethanol exposure.
However, CIE-dependent between-group differences emerged
at 24 h post-ethanol exposure in the number of action poten-
tials fired over a range of stimulus intensities, as revealed
by a significant repeated measures ANOVA (see Figure 3a
and b). Specifically, significant main effects of stimulus inten-
sity (F(20, 180)¼ 29.53, po0.001) and ethanol treatment
(F(1, 9)¼ 5.672, p¼ 0.0411) and a significant interaction
(F(20, 180)¼ 4.858, po0.001) were observed at 24 h post-
ethanol exposure. This effect was transient, as at 7 days post-
ethanol exposure, a repeated measures ANOVA indicated no
differences between CIE and AE mice (Figure 3c and d).
Together, these results indicate that chronic ethanol exposure
induces a short-term hyperexcitability of DR neurons.
Chronic Ethanol Exposure Alters Synaptic Transmission
in the DR
We next evaluated alterations in excitatory and inhibitory
synaptic transmission at 24 h and 7 days post ethanol
Figure 2 Chronic ethanol exposure (CIE) results in deficits in exploration at 24 h (a) and 7 days (b) post-ethanol exposure that are not altered by
pretreatment with the 5HT1A agonist buspirone. Deficits in social approach are observed following CIE are rescued by pretreatment with buspirone at both
24 h (c) and 7 days (d) post-ethanol exposure relative to air exposure (AE). * denotes significant between-group differences (po0.05); n¼ 9–10 mice per
group; error bars indicate SEM.
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exposure, by recording spontaneous excitatory postsynaptic
currents (sEPSCs) and inhibitory postsynaptic currents
(sIPSCs) in the same cell with temporal proximity and
computed a ratio of excitation/inhibition (E/I) to obtain a
relative measurement of net excitation or inhibition for
each cell. A significant increase in the spontaneous E/I
frequency (sE/I) of cells from CIE mice relative to AE mice
was observed at 24 h post-ethanol exposure (Welch’s
t(7.482)¼ 2.699, p¼ 0.0288; see Figure 4a). Further exam-
ination revealed that this effect was driven by reductions in
the frequency of sIPSCs in cells from CIE mice, although
this effect did not achieve statistical significance (Welch’s
t(7.385)¼ 1.983, p¼ 0.0856; see Figure 4b). No between-
group differences in sEPSC amplitude, sEPSC frequency,
or sIPSC amplitude were observed at this time point (see
Figure 4b and c). Although between-group differences in
sE/I frequency were not observed at 7 days post-ethanol
exposure (Figure 4d), a significant increase in sEPSC
amplitude was observed in cells from CIE relative to AE
mice (Welch’s t(8.682)¼ 3.587, p¼ 0.0062; Figure 4f). No
between-group differences in sEPSC frequency, sIPSC
amplitude, or sIPSC frequency were observed at this time
point (see Figure 4e and f). Network-independent altera-
tions in synaptic transmission following CIE were assessed
in the presence of the sodium channel blocker, TTX. At 24 h
post-ethanol exposure, no between-group differences in
miniature excitatory postsynaptic (mEPSC) or miniature
inhibitory postsynaptic (mIPSC) synaptic transmission
were observed (see Figure 4g–i). However, at 7 days post
CIE, a significant increase in miniature E/I frequency was
observed in cells from CIE mice relative to AE mice
(Welch’s t(10.91)¼ 2.639, p¼ 0.0232; see Figure 4j). Further
examination revealed that this effect was driven by a
significant increase in mEPSC frequency in these cells
(t(16)¼ 2.626; p¼ 0.0183; see Figure 4k). No other between-
group differences in network-independent synaptic trans-
mission were observed at this time point (Figure 4l).
Together, these results show that chronic ethanol exposure
induces short-term reductions in inhibitory transmission
and long-term enhancements in excitatory transmission in
the DR.
Acute Ethanol Exposure Enhances Inhibitory
Transmission in the DR Following Chronic Ethanol
Exposure
A previous investigation demonstrated that acute ethanol
application to slices prepared from ethanol-naive rats
enhanced GABAergic transmission in the DR (Lemos
et al, 2011). We hypothesized that a history of chronic
ethanol exposure would alter acute ethanol’s effects in the
DR. To test this hypothesis, we examined the effects of acute
bath application of ethanol (50 mM) on mIPSC frequency
and amplitude in cells from CIE and AE mice 24 h post-
ethanol exposure (see Figure 5). As shown in Figure 5a and
b, acute ethanol significantly enhanced mIPSC amplitude in
cells from both CIE and AE mice, revealed by a signifi-
cant main effect of time in a repeated measures ANOVA
(F(6, 102)¼ 3.551, p¼ 0.0031). However, the main effect of
ethanol treatment (CIE vs AE) and the interaction between
time and ethanol treatment were not significant (F(1, 17)¼
0.1590, p40.05 for the main effect; F(6, 102)¼ 1.066,
p40.05 for the interaction; see Figure 5b). The results
of paired t-tests did not reveal significant differences in
normalized mIPSC amplitude at baseline vs during acute
ethanol bath application (minute 14 of the experiment) for
Figure 3 Chronic ethanol exposure enhances the excitability of DR neurons during early withdrawal. Representative traces showing action potentials fired
in response to a 200 pA current injection in an air-exposed (AE) and chronic ethanol-exposed (CIE) mouse at 24 h post-ethanol exposure (a) and 7 days
post-ethanol exposure (c). Chronic ethanol exposure significantly enhanced the number of action potentials fired in response to an increasing step of current
at 24 h post-ethanol exposure (b) but not 7 days post-ethanol exposure (d) relative to AE. * denotes significant Bonferonni between-group differences
(po0.05); n¼ 5–6 cells per group from during early withdrawal and 7–8 cells per group during late withdrawal; error bars indicate SEM.
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Figure 4 Chronic ethanol alters synaptic transmission in the DR at 24 h post-ethanol exposure (a–c; g–i) and 7 days post-ethanol exposure (d–f; j–l). The
balance between spontaneous excitatory and inhibitory transmission (sE/I frequency) was shifted towards net excitation at 24 h post-ethanol exposure (CIE
24 h) relative to air exposure (AE 24 h; a). Alterations in spontaneous inhibitory (sIPSC frequency) and excitatory transmission (sEPSC frequency; b), and sIPSC
or sEPSC amplitude (c) were not observed. sE/I frequency (d), as well as sIPSC frequency and sEPSC frequency (e) at 7 days post- ethanol exposure (CIE 7
days) did not significantly differ from air exposure (AE 7 days). A significant increase in sEPSC amplitude was observed relative to AE at this time point (f). No
differences in the balance of miniature inhibitory and excitatory transmission (mE/I frequency), miniature inhibitory (mIPSC) or miniature excitatory (mEPSC)
transmission or amplitude were observed at 24 h post-ethanol exposure (CIE 24 h) relative to air exposure (AE 24 h; g–i). At 7 days post-ethanol exposure (CIE
7 days), the mE/I frequency was shifted toward net excitation relative to AE (AE 7 days; j), an effect that was driven by a significant enhancement of mEPSC
frequency (k). No differences in mIPSC or mEPSC amplitude were observed at this time point (l). * denotes significant between-group differences (po0.05);
n¼ 6–10 cells per group for 24 h post-ethanol exposure and 7–10 cells per group for 7 days post-ethanol exposure; error bars indicate SEM.
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Figure 5 Cells of the DR are more sensitive to the inhibitory effects of acute ethanol (50 mM) 24 h following chronic ethanol exposure.
(a) Representative traces showing miniature inhibitory transmission (mIPSCs) at baseline and during the final minute of 50 mM acute ethanol perfusion
(minute 14). (b) Acute ethanol modestly enhanced normalized mIPSC amplitude irrespective of chronic ethanol treatment. (c) Single subject plots show no
between-group differences in the effect of acute ethanol on mIPSC amplitude during the final minute of 50 mM acute ethanol perfusion and the normalized
mIPSC amplitude during acute ethanol did not significantly differ from baseline following chronic ethanol exposure (CIE 24 h) or air exposure (AE 24 h).
Horizontal bars denote the group means and standard error at this time point. (d) Acute ethanol significantly enhanced normalized mIPSC frequency
following chronic ethanol exposure (CIE 24 h) but not air exposure (AE 24 h). (e) Single subject plots show a significant increase in normalized mIPSC
frequency during the final minute of acute ethanol perfusion following CIE relative to AE. Normalized mIPSC frequency was significantly enhanced from
baseline following CIE but not following AE. Horizontal bars denote the group means at this time point. (f) Representative traces of an averaged mIPSC
events at baseline (black line) and during the final minute of acute ethanol perfusion (50 mM; gray line) following AE or CIE. (g) A significant increase in the
weighted tau was observed during the final minute of acute ethanol perfusion relative to baseline following CIE, but not following AE (data not shown).
* denotes significant between-group differences (po0.05); n¼ 9–10 cells per group; error bars indicate SEM.
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either CIE or AE mice (t(8)¼ 0.9890, p40.05 for CIE mice;
t(9)¼ 1.839, p40.05 for AE mice); between-group differ-
ences in normalized mIPSC amplitude during acute ethanol
bath application (minute 14) assessed using unpaired t-tests
were also not significant (t(17)¼ 0.7030, p40.05; see
Figure 5c). In contrast to effects on mIPSC amplitude,
acute ethanol effects on mIPSC frequency were significantly
different between CIE and AE mice, as revealed in a
repeated measures ANOVA by significant main effects of
time (F(6, 102)¼ 5.162, p¼ 0.001) and ethanol treatment
(F(1, 17)¼ 4.607, p¼ 0.0466) and a significant interaction
(F(6, 102)¼ 3.635, p¼ 0.0026; see Figure 5d). Bonferonni-
adjusted post hoc analyses indicated that normalized mIPSC
frequency was significantly enhanced by acute ethanol
following CIE, but not AE, at minutes 12 and 14. Likewise,
unpaired t-tests revealed a significant increase in normal-
ized mIPSC frequency during acute ethanol bath application
(minute 14) relative to baseline in cells from CIE mice
(t(8)¼ 2.773, p¼ 0.0242) but not in cells from AE mice
(t(9)¼ 0.6046, p40.05). Additionally, normalized mIPSC
frequency during acute ethanol (minute 14) was signifi-
cantly greater in CIE relative to AE mice (t(17)¼ 2.177,
p¼ 0.0438; Figure 5e). The decay kinetics of mIPSCs did not
differ between groups at baseline (t(16)¼ 0.7478, p40.05)
or during acute ethanol perfusion (analyzed at minute 14;
t(16)¼ 0.1853, p40.05), nor did acute ethanol alter decay
kinetics in AE mice (t(9)¼ 0.6168, p40.05; Figure 5f). In
CIE mice, acute ethanol significantly increased the weighted
decay tau (t(7)¼ 2.608, p¼ 0.0350; Figure 5g). A recent
report in ethanol-naive C57BL/6J mice shows that acute
ethanol induces a large tonic inward current mediated by
glycine receptors (Maguire et al, 2014). Thus, we assessed
whether acute ethanol produces a similar tonic current in
AE or CIE mice, but found that it did not (the mean
difference in holding current (pA) during baseline vs acute
ethanol was  6.86±2.96 pA for AE and  1.86±2.6 pA for
CIE and was not different between treatment groups,
t(15)¼ 1.196, p40.05).
DISCUSSION
Here, we provide an initial and novel characterization of
chronic ethanol effects on neurons of the DR, revealing a
potentially significant role for this circuit in the pathophy-
siology of alcoholism. First, we show that chronic ethanol
exposure enhances anxiety-like behavior during both early
and late withdrawal, an effect that involves the serotonin
system. At parallel time points, we show increases in the
net activity of DR neurons, manifested as hyperexcitability
and reduced inhibitory transmission during early withdrawal
and increased excitatory transmission during late withdrawal.
Further, we show that DR neurons are more sensitive to the
inhibitory effects of acute ethanol following chronic ethanol
exposure. On the basis of these findings, we propose that
increases in the net activity of DR neurons induced by
chronic ethanol contribute to enhanced anxiety during
ethanol withdrawal, and that by dampening this activity,
reintroduction of ethanol may provide relief from this
negative mood state. Taken together, these results demon-
strate that the DR is a critical site of neuroadaptations
contributing to the pathology of alcoholism.
Chronic Ethanol Exposure Enhances Anxiety-Like
Behavior in DBA2/J Mice
Impairments in sociability are a common feature of alcohol-
ism. Social anxiety is highly comorbid with alcoholism
(Schneier et al, 2010), and is reported as a precipitating factor
in excessive alcohol use (Buckner et al, 2008). Individuals
with alcoholism experience greater interpersonal conflict and
less social support (Dutton et al, 2014; Booth et al, 1992),
which may contribute to mood disorders that are often
comorbid in this population (Booth et al, 1992). A lack of
social engagement may contribute to poor treatment out-
comes, as treatment-seeking alcoholics who relapse report
more severe social difficulties than those who remain abstinent
(Charney et al, 2010). On the other hand, improving social
ties may promote treatment efforts (Booth et al, 1992; Richter
et al, 1991; Satre et al, 2012; Kelly et al, 2012), including
pharmacological interventions (Pettinati et al, 2009).
In agreement with these clinical observations and
previous studies in rats (Overstreet et al, 2002), we found
that chronic ethanol exposure impairs social approach in
DBA2/J mice. Previous preclinical characterization of this
behavior, relates this impairment to an increase in anxiety
(Moy et al, 2009; Meeker et al, 2013; Samaco et al, 2012;
Overstreet et al, 2002). The observed deficits in social
approach were lasting and could be normalized by
pretreatment with the 5HT1A agonist buspirone during
both early and late withdrawal. Previous work has shown a
similar effect of buspirone on anxiety during withdrawal
from chronic ethanol in rats when administered periph-
erally or into the DR (Overstreet et al, 2006; Overstreet et al,
2003). Interestingly, site-specific administration of bu-
sprione into the amygdala, nucleus accumbens, or para-
ventricular nucleus of the hypothalamus did not alter this
phenotype, suggesting that 5HT1A receptors within the DR
are particularly important for anxiety-like behavior during
withdrawal from ethanol (Overstreet et al, 2006). Taken
together, the results of the current study and the work of
Overstreet et al, (2006) demonstrate roles for both the DR
and serotonin in chronic ethanol-induced anxiety.
We also observed reduced exploration during the habitua-
tion period of the test among mice that underwent chronic
ethanol exposure, although this phenotype does not appear
to involve 5HT1A receptors. This effect of chronic ethanol
exposure was persistent, as it was observed at both early and
late withdrawal time points, therefore suggesting that reduced
exploration may be due to a lasting aversion to novelty rather
than feelings of physical illness that are typically observed
during acute withdrawal (ie, up to 8 h post ethanol exposure).
Interestingly, unlike chronic ethanol’s effect on social
approach, deficits in exploratory behavior were not rescued
by buspirone, suggesting that divergent neurochemical
systems or neural circuits may govern these behaviors. In
addition, this phenotype is consistent with findings from the
Breese group (Knapp et al, 2005). Importantly, these data also
demonstrate that deficits in exploratory behavior do not
impede the ability to engage in social approach behaviors.
Chronic Ethanol Effects on the DR
Although serotonin has long been implicated in alcoholism,
few studies to date have assessed ethanol’s effects on
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serotonin neurons or the larger circuit of the DR in which
they are contained. To our knowledge, the current study
provides the first evidence that synaptic transmission and
excitability within the DR are altered by chronic ethanol
exposure. With respect to synaptic transmission, we
observed a shift towards enhanced excitation during early
withdrawal that was driven by reductions in spontaneous
inhibitory transmission on the presynaptic side, perhaps
due to reductions in GABA release. Because changes in
network-independent inhibitory transmission were not
observed at this time point, these findings suggest that
chronic ethanol exposure may enhance the net activity of
DR neurons via adaptations that reduce the net activity of
DR interneurons, which are located primarily in the lateral
wings of the structure (Fu et al, 2010), thus resulting in
reduced GABA release. Although further investigation is
required to characterize alterations in release probability
and conclusively determine the source of GABA inputs that
are altered following chronic ethanol exposure, recent work
by Challis et al (2013) suggests that synapses between
interneurons and serotonin neurons are a significant site of
adaptations that confer behavioral pathology induced by
chronic stressors. Thus, it is reasonable to hypothesize that
this synapse is also a potential site of ethanol-induced
adaptations.
In addition to alterations in synaptic modulation, we
observed a significant enhancement of excitability during
early withdrawal from chronic ethanol exposure. Because
resting membrane potential, the threshold for excitation,
and the rheobase were not altered by chronic ethanol, this
finding reflects enhancements in neuronal activity that are
stimulation-dependent rather than an alteration in intrinsic
neuronal properties at rest. Such increases in excitability
could have functional consequences at downstream targets
of the DR, such as the nucleus accumbens, where serotonin
release is increased following chronic ethanol exposure
(Yoshimoto et al, 2012), or the central nucleus of the
amygdala, where serotonin receptor compounds normalize
chronic ethanol-induced anxiety-like behavior (Overstreet
et al, 2006). Indeed, enhanced serotonin activity during
periods of abstinence have documented effects on AUD-
related behavioral pathology, such as serotonin agonist-
induced exacerbation of anxiety and craving (Umhau et al,
2011) and SSRI-induced worsening of long-term drinking
outcomes in human alcoholics (Dundon et al, 2004).
Although further investigation is required to confirm that
chronic ethanol enhancement of net activity in the DR
confers increased serotonin output, our initial findings
provide insight into a potential mechanism by which the
serotonin system is dysregulated by chronic ethanol.
Although alterations in neuronal excitability and inhibi-
tory transmission were resolved during late withdrawal, a
shift toward excitation was still evident at this time point. In
contrast to early withdrawal, this shift was driven primarily
by enhancements in excitatory transmission. Specifically,
we observed a significant increase in spontaneous post-
synaptic excitatory transmission as well as a significant
increase in network-independent presynaptic excitatory
transmission, results that suggest changes in postsynaptic
glutamate receptor availability or types as well as increases
in presynaptic glutamate release. Enhanced presynaptic
excitatory transmission has also been observed in the DR
following exposure to forced swim stress (Kirby et al, 2007).
Interestingly, this effect was specific to serotonin neurons,
suggesting that this neuronal population may be particu-
larly sensitive to stressors and perhaps chronic ethanol
exposure. Considering that glutamatergic activity in the DR
has been implicated in stress-induced behavioral changes
related to negative mood states (Grahn et al, 2000),
enhanced excitatory transmission in the DR induced by
chronic ethanol may contribute to increases in anxiety-like
behavior during withdrawal although further examination is
required to confirm this possibility. The observed altera-
tions in synaptic transmission during both early and late
withdrawal are particularly interesting in light of emerging
data showing that GABA bidirectionally modulates gluta-
mate release onto DR neurons (Soiza-Reilly et al, 2013).
Thus, reductions in GABA transmission during early
withdrawal may facilitate adaptations resulting in enhanced
glutamate release during late withdrawal.
Acute Ethanol Effects in the DR
We found that following chronic ethanol exposure, cells
from the DR are more sensitive to the inhibitory effects of a
moderate concentration of ethanol applied acutely to slices.
In contrast to ethanol-naive (both AE and naive) mice, in
which postsynaptic inhibition is enhanced by acute ethanol
without an appreciable effect on presynaptic inhibition,
both pre- and postsynaptic inhibition is enhanced by acute
ethanol following chronic ethanol treatment. Indeed, while
acute ethanol enhances postsynaptic GABA transmission in
the DR of both ethanol-naive and chronically exposed mice,
the decay kinetics of inhibitory events were slower during
acute ethanol perfusion only following chronic ethanol
exposure. Thus, the postsynaptic effect of acute ethanol is
augmented by chronic ethanol exposure. Further, we found
that although basal GABA transmission is not altered
by chronic ethanol, presynaptic mechanisms are engaged
by acute ethanol exclusively following chronic ethanol
exposure, conferring increased GABA release. This effect
contrasts with previous observations in the central nucleus
of the amygdala, where chronic ethanol exposure results in
enhanced basal levels of GABA that are augmented further
by reintroduction of acute ethanol (Roberto et al, 2010).
Acute ethanol facilitation of inhibitory transmission in
the DR has been reported previously in ethanol-naive
rodents. In contrast with our findings, an initial investiga-
tion found that moderate concentrations of acute ethanol
enhances both pre- and postsynaptic GABAA receptor
mediated transmission in rats (Lemos et al, 2011), perhaps
reflecting a species difference in acute ethanol responses. In
addition, recent findings suggest that strain may also be a
factor in differential effects of ethanol as a recent report
shows enhancement of only presynaptic GABAA receptor
mediated transmission in ethanol-naive C57BL/6J mice
(Maguire et al, 2014). In addition to effects on GABA
transmission, acute ethanol activated a large tonic inward
current mediated by extrasynaptic glycine receptors in the
DR of C57BL/6J mice. In the current study conducted in
DBA2/J mice, we found no evidence of an ethanol-induced
tonic current under naive or chronic ethanol conditions.
Thus, DBA2/J mice and C57BL/6J mice appear to funda-
mentally differ in aspects of inhibitory modulation of the
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DR. In support of this possibility, there is evidence showing
basal differences in GABA transmission in the basolateral
amygdala of these mouse strains (Dubois et al, 2006). It is of
note that these strains also differ behaviorally, with DBA2/J
mice showing higher levels of basal anxiety than C57BL/6J
mice (Dubois et al, 2006). Likewise, C57BL/6J mice appear
to be resistant to chronic ethanol-induced anxiety (Cox
et al, 2013), whereas the current results show that DBA2/J
mice are vulnerable. It will be interesting to ascertain
whether such behavioral differences arise from strain
differences in DR function and/or serotonin activity.
CONCLUSIONS
The present findings demonstrate that chronic ethanol
exposure enhances the net activity of DR neurons at time
points during withdrawal when anxiety-like behavior is
increased. Because the inhibitory effects of acute ethanol are
augmented following chronic ethanol treatment, reintro-
duction of acute ethanol appears to functionally oppose
withdrawal effects on GABA transmission in the DR. As
such, the DR may have a critical role in the negative
reinforcing properties of acute ethanol that have been
linked with relapse in alcoholic populations. Overall, these
results provide the first compelling evidence implicating
chronic ethanol-induced hyperactivity in the DR as a
potential mechanism underlying ethanol-related behavioral
pathologies related to serotonin that have been extensively
documented in the literature.
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